Vaginal Infection

0
Pipeline Programs
2
Companies
2
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Bioperfectus
BioperfectusChina - Shanghai
1 program
Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram StainingN/A1 trial
Active Trials
NCT05997160UnknownEst. Jun 2025
Carbon Biosciences
Carbon BiosciencesMA - Waltham
1 program
Vaginal swab for RT-PCRN/A1 trial
Active Trials
NCT05557318RecruitingEst. Oct 2025

Trial Timeline

Clinical trial activity over time

2022
2023
2024
2025
2026
BioperfectusResearch on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining
Carbon BiosciencesVaginal swab for RT-PCR

Clinical Trials (2)

NCT05997160BioperfectusResearch on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining

Research on Vaginal Microbiota Evaluation Unified Standards Based on Gram Staining

Start: Sep 2023Est. completion: Jun 2025
N/AUnknown
NCT05557318Carbon BiosciencesVaginal swab for RT-PCR

Using Micro Electro Mechanical Systems to Detect the Air of Vaginal Discharge

Start: Oct 2022Est. completion: Oct 2025
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials
2 companies competing in this space